CA2172401A1 - Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active - Google Patents

Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active

Info

Publication number
CA2172401A1
CA2172401A1 CA002172401A CA2172401A CA2172401A1 CA 2172401 A1 CA2172401 A1 CA 2172401A1 CA 002172401 A CA002172401 A CA 002172401A CA 2172401 A CA2172401 A CA 2172401A CA 2172401 A1 CA2172401 A1 CA 2172401A1
Authority
CA
Canada
Prior art keywords
active substance
acetylsalicylic acid
therapeutic system
transdermal therapeutic
matrix layers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002172401A
Other languages
English (en)
Other versions
CA2172401C (fr
Inventor
Michael Horstmann
Gerd Hoffmann
Heinrich Kindel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4332093A external-priority patent/DE4332093C2/de
Application filed by Individual filed Critical Individual
Publication of CA2172401A1 publication Critical patent/CA2172401A1/fr
Application granted granted Critical
Publication of CA2172401C publication Critical patent/CA2172401C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002172401A 1993-09-22 1994-09-16 Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active Expired - Fee Related CA2172401C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4332093.7 1993-09-22
DE4332093A DE4332093C2 (de) 1993-09-22 1993-09-22 Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
PCT/EP1994/003106 WO1995008330A1 (fr) 1993-09-22 1994-09-16 Systeme therapeutique transdermique contenant comme principe actif l'acide acetylsalicylique

Publications (2)

Publication Number Publication Date
CA2172401A1 true CA2172401A1 (fr) 1995-03-30
CA2172401C CA2172401C (fr) 2005-11-15

Family

ID=35520907

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002172401A Expired - Fee Related CA2172401C (fr) 1993-09-22 1994-09-16 Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active

Country Status (1)

Country Link
CA (1) CA2172401C (fr)

Also Published As

Publication number Publication date
CA2172401C (fr) 2005-11-15

Similar Documents

Publication Publication Date Title
AU7782794A (en) Transdermal therapeutic system with acetylsalicylic acid as active substance
CA2196840A1 (fr) Comprime pharmaceutique pouvant liberer l'ingredient actif intervalles subsequents predetermines
CA2227202A1 (fr) Systeme therapeutique transdermique pour l'administration par la peau de principes actifs dans le corps humain
WO1994008571A3 (fr) Emplatre pour administration percutanee d'ingredients volatils, chimiquement basiques, pharmaceutiquement actifs, et son procede de preparation
CA2147172A1 (fr) Systeme therapeutique transdermique pour liberation de 17-.beta.-oestradiol, et mode de production
CA2139929A1 (fr) Systeme therapeutique transdermique contenant la substance active 17-.beta.-o estradiol (anhydre)
CA2007353A1 (fr) Systeme therapeutique superficiel comprenant une substance antineoplastique active, particulierement du 5-fluorouracil
CA2172401A1 (fr) Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active
CA2260845A1 (fr) Preparation orale renfermant, dans une matrice capable de gonflemment en milieu aqueux, au moins une substance active pharmaceutique
CA2239952A1 (fr) Preparation pharmaceutique a surface stabilisee pour application sur la peau
CA2197865A1 (fr) Systeme therapeutique transdermique renfermant de l'oestradiol et des additifs hydrophiles
CA2197867A1 (fr) Systeme therapeutique transdermique renfermant de l'oestradiol et des additifs hydrophiles
YU49193A (sh) Transdermalni terapijski sistem sa aktivnom materijom bezvodnim 17-beta-estradiolom
CA2198092A1 (fr) Systeme therapeutique transdermique avec protection contre l'hydrolyse

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130917